Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$191M |
| 2 |
Nike
NKE
|
+$190M |
| 3 |
UnitedHealth
UNH
|
+$158M |
| 4 |
Shopify
SHOP
|
+$153M |
| 5 |
TSMC
TSM
|
+$151M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palantir
PLTR
|
+$910M |
| 2 |
Microsoft
MSFT
|
+$668M |
| 3 |
Meta Platforms (Facebook)
META
|
+$351M |
| 4 |
Micron Technology
MU
|
+$244M |
| 5 |
Apple
AAPL
|
+$191M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.86% |
| 2 | Healthcare | 15.8% |
| 3 | Consumer Discretionary | 14.09% |
| 4 | Industrials | 8.98% |
| 5 | Financials | 8.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2876
Fulgent Genetics
FLGT
$527M
| $460K | ﹤0.01% |
24,900
-8,100
| -25% | -$158K |
|
2877
Genasys
GNSS
$79.2M
| $460K | ﹤0.01% |
176,836
-14,100
| -7% | -$49.4K |
|
2878
Nelnet
NNI
$4.89B
| $459K | ﹤0.01% |
4,300
-8,600
| -67% | -$951K |
|
2879
Hydrofarm Holdings
HYFM
$9.15M
| $458K | ﹤0.01% |
78,997
+3,637
| +5% | +$23.8K |
|
|
SWKH
2880
DELISTED
SWK Holdings
SWKH
| $458K | ﹤0.01% |
36,450
+1,307
| +4% | +$17K |
|
2881
Fidelity MSCI Consumer Discretionary Index ETF
FDIS
$1.73B
| $458K | ﹤0.01% |
+4,700
| New | +$440K |
|
2882
Vita Coco
COCO
$3.73B
| $458K | ﹤0.01% |
+12,400
| New | +$413K |
|
2883
Pyxis Oncology
PYXS
$200M
| $458K | ﹤0.01% |
293,354
+133,018
| +83% | +$384K |
|
|
USAS
2884
Americas Gold and Silver
USAS
$1.48B
| $457K | ﹤0.01% |
486,480
+81,040
| +20% | +$82.3K |
|
2885
Aligos Therapeutics
ALGS
$29.4M
| $456K | ﹤0.01% |
11,443
-2,000
| -15% | -$38.6K |
|
|
RPTX
2886
DELISTED
Repare Therapeutics
RPTX
| $455K | ﹤0.01% |
347,460
-106,240
| -23% | -$316K |
|
2887
CareCloud
CCLD
$110M
| $454K | ﹤0.01% |
124,100
+8,100
| +7% | +$24.1K |
|
2888
Betterware México
BWMX
$637M
| $454K | ﹤0.01% |
40,600
-2,400
| -6% | -$29.4K |
|
2889
IBEX
IBEX
$485M
| $453K | ﹤0.01% |
21,100
-24,100
| -53% | -$474K |
|
2890
Greene County Bancorp
GCBC
$590M
| $452K | ﹤0.01% |
16,300
+8,900
| +120% | +$269K |
|
2891
Ivanhoe Electric
IE
$1.66B
| $451K | ﹤0.01% |
+59,700
| New | +$552K |
|
2892
Vanguard Consumer Discretionary ETF
VCR
$6.3B
| $450K | ﹤0.01% |
1,200
+400
| +50% | +$144K |
|
|
SGRP
2893
DELISTED
SPAR Group
SGRP
| $450K | ﹤0.01% |
231,794
+13,794
| +6% | +$30.9K |
|
2894
Kodak
KODK
$874M
| $449K | ﹤0.01% |
68,345
-3,955
| -5% | -$22.5K |
|
2895
Portillo's
PTLO
$328M
| $447K | ﹤0.01% |
+47,597
| New | +$544K |
|
|
ELSE
2896
DELISTED
Electro-Sensors
ELSE
| $445K | ﹤0.01% |
86,200
-3,600
| -4% | -$15.6K |
|
2897
NorthWestern Energy
NWE
$4.3B
| $445K | ﹤0.01% |
+8,326
| New | +$453K |
|
2898
Inovio Pharmaceuticals
INO
$68.5M
| $443K | ﹤0.01% |
242,305
-88,761
| -27% | -$393K |
|
2899
Acumen Pharmaceuticals
ABOS
$162M
| $442K | ﹤0.01% |
257,213
-48,887
| -16% | -$118K |
|
2900
Regis Corp
RGS
$66.2M
| $442K | ﹤0.01% |
18,646
+4,640
| +33% | +$110K |
|
Similar funds
Renaissance Technologies's Q4 2024 Portfolio in Review
As of Q4 2024, Renaissance Technologies held 4,032 positions worth $67.6B, up 1.6% from $66.5B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Renaissance Technologies's Q4 2024 filing shows 548 new, 1,485 increased, 1,480 reduced and 497 closed positions. Its largest new stake was UnitedHealth: 278,658 shares worth $141M. The largest sale was Palantir, an estimated $910M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Renaissance Technologies's largest Q4 2024 buy was UnitedHealth: 278,658 shares worth $141M.
- Renaissance Technologies added most to Alibaba in Q4 2024, an estimated $191M increase.
- Renaissance Technologies's biggest Q4 2024 reduction was Palantir, cutting an estimated $910M.
- Renaissance Technologies fully exited Arm in Q4 2024, selling an estimated $153M.
- Renaissance Technologies's ten largest holdings make up 10% of its $67.6B portfolio in Q4 2024.
- Renaissance Technologies opened 548 new positions and closed 497 in Q4 2024.
- Renaissance Technologies's portfolio value rose 1.6% quarter-over-quarter to $67.6B.
Based on Renaissance Technologies's 13F filing for Q4 2024, filed 13 Feb 2025.